History
  • No items yet
midpage
881 F. Supp. 2d 1333
N.D. Ala.
2012
Read the full case

Background

  • MDL product liability action concerning Chantix (varenicline) for smoking cessation.
  • FDA approved Chantix in May 2006; plaintiffs allege neuropsychiatric harms including depression and suicidality.
  • Label warnings evolved, culminating in a July 2009 black box warning and a concurrent Medication Guide.
  • Plaintiffs argue the 2009 warning is insufficient and seeks to toll or trigger statute-of-limitations issues; defendant argues the 2009 warning is adequate as a matter of law.
  • Court applies learned intermediary doctrine, attributing warnings to physicians; focus is on adequacy of the 2009 label and its impact on liability.
  • Court distinguishes post-2009 claims and allows case-specific challenges to limitations timing rather than a blanket ruling.

Issues

Issue Plaintiff's Argument Defendant's Argument Held
Adequacy of the 2009 boxed warning Glenmullen supports inadequacy of 2009 warning Label adequately warns of neuropsychiatric risks 2009 warning deemed adequate as a matter of law
Statute of limitations timing Running of limitations cannot be blanketly tied to 2009 warning Limitations should start after July 1, 2009 Case-by-case analysis; allow motions in individual cases; not a blanket ruling
Role of learned intermediary doctrine Physician warning to patient remains inadequate irrespective of doctor judgment Warning to physicians suffices; doctors decide prescribing Court sustains sufficiency of physician-directed warning under learned intermediary doctrine

Key Cases Cited

  • Wyeth v. Levine, 555 U.S. 555 (U.S. 2009) (drug labeling duty to update warnings; post-market obligations)
  • PLIVA, Inc. v. Mensing, 131 S. Ct. 2567 (S. Ct. 2011) (federal preemption and labeling duty standards)
  • Toole v. Baxter Healthcare Corp., 235 F.3d 1307 (11th Cir. 2000) (learned intermediary doctrine governs warnings for prescription drugs)
  • Anderson v. Sandoz Pharma. Corp., 77 F. Supp. 2d 804 (S.D. Fla. 1999) (learned intermediary doctrine; physician as warning recipient)
  • Caveny v. CIBA-GEIGY Corp., 818 F. Supp. 1404 (D. Colo. 1992) (manufacturer's warning adequate as a matter of law when clearly informs risks)
Read the full case

Case Details

Case Name: In re Chantix (Varenicline) Products Liability Litigation
Court Name: District Court, N.D. Alabama
Date Published: Jul 23, 2012
Citations: 881 F. Supp. 2d 1333; 2012 WL 3030097; Master File No. 2:09-CV-2039-IPJ; MDL No. 2092
Docket Number: Master File No. 2:09-CV-2039-IPJ; MDL No. 2092
Court Abbreviation: N.D. Ala.
Log In
    In re Chantix (Varenicline) Products Liability Litigation, 881 F. Supp. 2d 1333